FDA says it is expediting the use of a blood plasma treatment as NY begins to roll out new clinical trials

FDA says it is expediting the use of a blood plasma treatment as NY begins to roll out new clinical trials





The US Food and Drug Administration on Tuesday said it is expediting the use of a blood plasma treatment for patients seriously ill with the coronavirus, making it easier for doctors to try another tool to attack the illness.








News

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.